Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions [[electronic resource] ] : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 |
Descrizione fisica | 1 online resource (XII, 314 p. 95 illus., 91 illus. in color.) |
Disciplina | 353.998 |
Soggetto topico |
Pharmacy
Pharmacology Drug Safety and Pharmacovigilance Pharmacology/Toxicology |
ISBN | 981-13-1489-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions. |
Record Nr. | UNINA-9910350239403321 |
Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiovascular Safety in Drug Development and Therapeutic Use [[electronic resource] ] : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari |
Autore | Turner J. Rick |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 |
Descrizione fisica | 1 online resource (XXVI, 333 p. 2 illus. in color.) |
Disciplina | 353.998 |
Soggetto topico |
Pharmacy
Cardiology Drug Safety and Pharmacovigilance |
ISBN | 3-319-40347-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | The Central Importance of Cardiovascular Safety in Contemporary New Drug Development -- The Biological Basis of Drug Responses -- Cardiovascular Structure, Function, Pathophysiology, & Disease -- The Current Regulatory Landscape -- The "Comprehensive In Vitro Proarrhythmia Assay" Initiative -- The "Early ECG Assessment" Initiative -- The "Submission of Extended Digital ECG Data" Initiative -- Meta-analysis and Meta-methodology -- Current Regulatory Landscapes and their Potential Evolution -- Off-target Blood Pressure Responses to Non-cardiovascular Drugs -- Oncology Drug Development and Therapeutics: Cardiotoxicity Considerations -- Postmarketing Surveillance -- Regulatory Perspectives on General Drug Safety -- Future Directions in Cardiovascular Safety -- References. |
Record Nr. | UNINA-9910254496803321 |
Turner J. Rick
![]() |
||
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Drug safety |
Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
Disciplina |
353.998
610 |
Soggetto topico |
Drugs - Side effects
Drugs - Toxicology Toxicology Pharmacoepidemiology Drug-Related Side Effects and Adverse Reactions Pharmacoépidémiologie Médicaments - Effets secondaires Médicaments - Toxicologie Toxicologie toxicology |
Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. periodicals. Périodiques. |
ISSN | 1179-1942 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996202316703316 |
[Mairangi Bay, Auckland, N.Z.], : Adis International | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Drug safety |
Pubbl/distr/stampa | [Mairangi Bay, Auckland, N.Z.], : Adis International |
Disciplina |
353.998
610 |
Soggetto topico |
Drugs - Side effects
Drugs - Toxicology Toxicology Pharmacoepidemiology Drug-Related Side Effects and Adverse Reactions Pharmacoépidémiologie Médicaments - Effets secondaires Médicaments - Toxicologie Toxicologie toxicology |
Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. periodicals. Périodiques. |
ISSN | 1179-1942 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910481986503321 |
[Mairangi Bay, Auckland, N.Z.], : Adis International | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmacovigilance [[electronic resource] ] : Critique and Ways Forward / / edited by I. Ralph Edwards, Marie Lindquist |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 |
Descrizione fisica | 1 online resource (XXXI, 205 p. 16 illus., 3 illus. in color.) |
Disciplina | 353.998 |
Soggetto topico |
Pharmacy
Drug Safety and Pharmacovigilance |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. How to learn Pharmacovigilance, now and in the Future -- 2. Lost in Regulation -- 3. What is the Future of Pharmacovigilance and how can we Make it as Good as Possible? -- 4. Some Other Ideas About the Future of Pharmacovigilance -- 5. Best Safety Practices now and in the Future -- 6. Is There a Benefit from the Medical Literature Monitoring Service of the EMA? -- 7. The Unified Drug Safety-Clinical Database -- 8. Behind the Scenes – ‘Silent Factors’ Influencing Pharmacovigilance Practice and Decisions -- 9. Shaking up Culture and Communication in PV [V6] -- 10. Broadening the Scope of Pharmacovigilance -- 11. Effective Treatment Matters: Revitalizing Pharmacoviglance -- 12. There are More Weber-Effects -- 13. Herbal and Traditional Medicines, Now and Future -- 14. The Concept of ‘Health’ -- 15. Impact of Referral Procedures on the Interaction of RMP and PSUR -- 16. Other Sources of Information for Monitoring Drug Safety: Now and in the Future -- 17. Ecopharmacovigilance. |
Record Nr. | UNINA-9910148857703321 |
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Quick Guide to Good Clinical Practice [[electronic resource] ] : How to Meet International Quality Standard in Clinical Research / / by Cemal Cingi, Nuray Bayar Muluk |
Autore | Cingi Cemal |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
Descrizione fisica | 1 online resource (XVIII, 237 p.) |
Disciplina | 353.998 |
Soggetto topico |
Pharmacy
Statistics Surgery Medical education Drug Safety and Pharmacovigilance Statistics for Life Sciences, Medicine, Health Sciences General Surgery Medical Education |
ISBN | 3-319-44344-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1 Clinical Trials: Historical Aspects and Importance and New Drug Developments -- 2 The Definition of GCP -- 3 The Principles of GCP -- 4 The Drug Development Process and Evolution of Regulations -- 5 Planning Clinical Research -- 6 Preparation of Ethics Committee (IRB) Proposal -- 7 Preparation of Informed Consent -- 8 Preparation of Findings Tables -- 9 Setting the Ideal Statistical Methods -- 10 The Duties of a Clinical Research Coordinator -- 11 The Duties of Clinical Researchers -- 12 The Phases of Clinical Studies -- 13 Safety in Clinical Trials -- 14 Setting the Size -- 15 Setting the Ideal Method -- 16 Ethics of Clinical Research -- 17 Recruitment and Enrolment -- 18 Why we need Clinical Consent and Other Documentation -- 19 Monitoring the Trial -- 20 Inspection -- 21 Ethics - Institutional Review Board/Independent Ethics Committee(IRB/IEC) -- 22 Responsibilities of the Investigator -- 23 Responsibilities of the Sponsor -- 24.Clinical Trial Protocols. |
Record Nr. | UNINA-9910151663203321 |
Cingi Cemal
![]() |
||
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|